hotspot -WSS

hotspot

author：leisure time 2025-09-30 20:05:56 - browse：92

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Couple fighting to bring baby home from Mexico are finally reunited

WSS

DOJ, FTC to increase scrutiny of all types of health care mergers

Changes to biosimilar regulatory framework must prioritize patients

CDC's new outbreak response network to include Northeastern

Experts study whether long Covid risk adds up with each reinfection

Ukraine and a new approach to mental health in war

Intarcia’s device

entertainment

hotspot

knowledge

In age of alternative facts, a scholarly course on calling out crap

Stanford updates investigation of president’s past research

Medical leaders decry Supreme Court decision on affirmative action

Lasker Awards 2023: Winners in biomedical research

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Intarcia’s device

Peter Hotez and the public health issue of online harassment

India sets sights on home

Wildfire smoke exposes gaps in outdoor worker protections

Readout LOUD podcast: possible new ALS drug, artificial wombs

explore

Microbiome research is starting to find links to chronic diseases

CDC's new outbreak response network to include Northeastern

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

DOJ, FTC to increase scrutiny of all types of health care mergers

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

It's been 20 years since Dolly the sheep. Where's my clone?

hotspot

focus

explore

knowledge